

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.74172845 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.74172845 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.40526751 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.40526751 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.19649600 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.17862515 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.71774952 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.71774952 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.71774952 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.47718298 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.44634166 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.44458874 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.42666104 |
| 14 | protein carboxylation (GO:0018214) | 5.42666104 |
| 15 | complement activation, alternative pathway (GO:0006957) | 5.41586779 |
| 16 | urea cycle (GO:0000050) | 5.30610046 |
| 17 | urea metabolic process (GO:0019627) | 5.30610046 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.29710420 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.21515036 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 5.20690929 |
| 21 | regulation of protein activation cascade (GO:2000257) | 5.16054414 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.15788561 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.15486536 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 5.05736876 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 5.05736876 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.05736876 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.05736876 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.05736876 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 5.05736876 |
| 30 | regulation of fibrinolysis (GO:0051917) | 5.04684521 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 4.95192840 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.94912384 |
| 33 | response to peptidoglycan (GO:0032494) | 4.90527200 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 4.87496642 |
| 35 | sulfur amino acid catabolic process (GO:0000098) | 4.87010199 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.85349301 |
| 37 | regulation of complement activation (GO:0030449) | 4.85226243 |
| 38 | reverse cholesterol transport (GO:0043691) | 4.79990208 |
| 39 | detection of other organism (GO:0098543) | 4.76426295 |
| 40 | cysteine metabolic process (GO:0006534) | 4.74435421 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.70836736 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.70274131 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.70274131 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.70274131 |
| 45 | macrophage activation involved in immune response (GO:0002281) | 4.64299077 |
| 46 | bile acid metabolic process (GO:0008206) | 4.59632607 |
| 47 | detection of external biotic stimulus (GO:0098581) | 4.59301436 |
| 48 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.58635137 |
| 49 | phospholipid efflux (GO:0033700) | 4.58201337 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 4.55436643 |
| 51 | homocysteine metabolic process (GO:0050667) | 4.53488138 |
| 52 | aromatic amino acid family metabolic process (GO:0009072) | 4.46675616 |
| 53 | serine family amino acid catabolic process (GO:0009071) | 4.46674981 |
| 54 | tyrosine metabolic process (GO:0006570) | 4.42992899 |
| 55 | cellular extravasation (GO:0045123) | 4.40673480 |
| 56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.37240154 |
| 57 | detection of bacterium (GO:0016045) | 4.34677588 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.32708840 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.32708840 |
| 60 | negative regulation of cholesterol transport (GO:0032375) | 4.21318648 |
| 61 | negative regulation of sterol transport (GO:0032372) | 4.21318648 |
| 62 | microglial cell activation (GO:0001774) | 4.20400738 |
| 63 | amino-acid betaine metabolic process (GO:0006577) | 4.18694367 |
| 64 | aldehyde catabolic process (GO:0046185) | 4.18172263 |
| 65 | cholesterol efflux (GO:0033344) | 4.17919576 |
| 66 | detection of biotic stimulus (GO:0009595) | 4.11938394 |
| 67 | negative regulation of cell killing (GO:0031342) | 4.11795191 |
| 68 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.11795191 |
| 69 | alpha-amino acid catabolic process (GO:1901606) | 4.10208253 |
| 70 | low-density lipoprotein particle remodeling (GO:0034374) | 4.09758774 |
| 71 | cellular glucuronidation (GO:0052695) | 4.08183634 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 4.07489451 |
| 73 | fibrinolysis (GO:0042730) | 4.06569661 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 4.06084372 |
| 75 | amine catabolic process (GO:0009310) | 4.06084372 |
| 76 | lysine catabolic process (GO:0006554) | 4.01660731 |
| 77 | lysine metabolic process (GO:0006553) | 4.01660731 |
| 78 | negative regulation of interleukin-12 production (GO:0032695) | 3.93584790 |
| 79 | bile acid and bile salt transport (GO:0015721) | 3.92596846 |
| 80 | positive regulation of lipid catabolic process (GO:0050996) | 3.90066545 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.87759795 |
| 82 | cellular ketone body metabolic process (GO:0046950) | 3.87688019 |
| 83 | macrophage activation (GO:0042116) | 3.87271028 |
| 84 | coenzyme catabolic process (GO:0009109) | 3.86014754 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 3.84901932 |
| 86 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.80760866 |
| 87 | uronic acid metabolic process (GO:0006063) | 3.79672497 |
| 88 | glucuronate metabolic process (GO:0019585) | 3.79672497 |
| 89 | immunoglobulin mediated immune response (GO:0016064) | 3.77357133 |
| 90 | cellular amino acid catabolic process (GO:0009063) | 3.77063457 |
| 91 | arginine metabolic process (GO:0006525) | 3.73772640 |
| 92 | imidazole-containing compound metabolic process (GO:0052803) | 3.73373934 |
| 93 | cofactor catabolic process (GO:0051187) | 3.72045993 |
| 94 | acute-phase response (GO:0006953) | 3.71308665 |
| 95 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.69059441 |
| 96 | complement activation (GO:0006956) | 3.68407349 |
| 97 | protein activation cascade (GO:0072376) | 3.68011427 |
| 98 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.67374137 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.67374137 |
| 100 | plasma lipoprotein particle organization (GO:0071827) | 3.66425393 |
| 101 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.65888965 |
| 102 | regulation of gamma-delta T cell activation (GO:0046643) | 3.65876904 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.65583617 |
| 104 | cellular modified amino acid catabolic process (GO:0042219) | 3.64858246 |
| 105 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.64451684 |
| 106 | blood coagulation, intrinsic pathway (GO:0007597) | 3.64294782 |
| 107 | glutamate metabolic process (GO:0006536) | 3.63903400 |
| 108 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.62740699 |
| 109 | opsonization (GO:0008228) | 3.61248473 |
| 110 | complement activation, classical pathway (GO:0006958) | 3.59262606 |
| 111 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.59157310 |
| 112 | response to host immune response (GO:0052572) | 3.59157310 |
| 113 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.58215948 |
| 114 | glycine metabolic process (GO:0006544) | 3.57454655 |
| 115 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.56023611 |
| 116 | cholesterol homeostasis (GO:0042632) | 3.52850640 |
| 117 | ethanol oxidation (GO:0006069) | 3.52306617 |
| 118 | NAD biosynthetic process (GO:0009435) | 3.50388991 |
| 119 | serine family amino acid metabolic process (GO:0009069) | 3.49411694 |
| 120 | protein-lipid complex assembly (GO:0065005) | 3.48176851 |
| 121 | sterol homeostasis (GO:0055092) | 3.48090415 |
| 122 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.47795451 |
| 123 | neutrophil activation (GO:0042119) | 3.47556656 |
| 124 | drug catabolic process (GO:0042737) | 3.46303372 |
| 125 | negative regulation of lipase activity (GO:0060192) | 3.46035239 |
| 126 | protein-lipid complex subunit organization (GO:0071825) | 3.44818162 |
| 127 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.44094075 |
| 128 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.44094075 |
| 129 | positive regulation of mast cell activation (GO:0033005) | 3.43481688 |
| 130 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.43187915 |
| 131 | lipoprotein metabolic process (GO:0042157) | 3.41127061 |
| 132 | neutrophil mediated immunity (GO:0002446) | 3.40015702 |
| 133 | regulation of mast cell degranulation (GO:0043304) | 3.36840165 |
| 134 | carboxylic acid catabolic process (GO:0046395) | 3.36447676 |
| 135 | organic acid catabolic process (GO:0016054) | 3.36447676 |
| 136 | regulation of plasminogen activation (GO:0010755) | 3.35713919 |
| 137 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.35184247 |
| 138 | myeloid cell activation involved in immune response (GO:0002275) | 3.33667781 |
| 139 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.28755448 |
| 140 | response to host (GO:0075136) | 3.28755448 |
| 141 | response to host defenses (GO:0052200) | 3.28755448 |
| 142 | granulocyte activation (GO:0036230) | 3.21633829 |
| 143 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.20725561 |
| 144 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.19447770 |
| 145 | positive regulation of mast cell degranulation (GO:0043306) | 3.18702792 |
| 146 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.18702792 |
| 147 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.17486720 |
| 148 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.14338402 |
| 149 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.11708756 |
| 150 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.09679976 |
| 151 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.08848788 |
| 152 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.08654776 |
| 153 | respiratory burst (GO:0045730) | 3.04589125 |
| 154 | regulation of mast cell activation (GO:0033003) | 3.02002607 |
| 155 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.00744853 |
| 156 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.98419353 |
| 157 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.98419353 |
| 158 | response to muramyl dipeptide (GO:0032495) | 2.98236011 |
| 159 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.96743541 |
| 160 | regulation of leukocyte degranulation (GO:0043300) | 2.96106102 |
| 161 | negative regulation of protein activation cascade (GO:2000258) | 2.94359846 |
| 162 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.93302953 |
| 163 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.92941892 |
| 164 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.84377779 |
| 165 | negative regulation of complement activation (GO:0045916) | 2.84265786 |
| 166 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.82847521 |
| 167 | myeloid leukocyte mediated immunity (GO:0002444) | 2.82737423 |
| 168 | positive regulation of B cell differentiation (GO:0045579) | 2.81231150 |
| 169 | B cell mediated immunity (GO:0019724) | 2.79713126 |
| 170 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79639970 |
| 171 | negative regulation of humoral immune response (GO:0002921) | 2.78032308 |
| 172 | T-helper 1 type immune response (GO:0042088) | 2.77530040 |
| 173 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.75999020 |
| 174 | negative regulation of T cell mediated immunity (GO:0002710) | 2.74476832 |
| 175 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.72794432 |
| 176 | regulation of tolerance induction (GO:0002643) | 2.72244318 |
| 177 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.68627213 |
| 178 | regulation of growth of symbiont in host (GO:0044126) | 2.68627213 |
| 179 | negative regulation of growth of symbiont in host (GO:0044130) | 2.68627213 |
| 180 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.68627213 |
| 181 | leukocyte aggregation (GO:0070486) | 2.66904237 |
| 182 | regulation of humoral immune response (GO:0002920) | 2.66812959 |
| 183 | regulation of macrophage cytokine production (GO:0010935) | 2.62850156 |
| 184 | defense response to protozoan (GO:0042832) | 2.60858506 |
| 185 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.60436999 |
| 186 | positive regulation of leukocyte degranulation (GO:0043302) | 2.60026300 |
| 187 | positive regulation of interferon-alpha production (GO:0032727) | 2.59285290 |
| 188 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.59141104 |
| 189 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.56851799 |
| 190 | B cell receptor signaling pathway (GO:0050853) | 2.56523921 |
| 191 | epoxygenase P450 pathway (GO:0019373) | 2.56048752 |
| 192 | negative regulation of interleukin-6 production (GO:0032715) | 2.55406654 |
| 193 | myeloid leukocyte activation (GO:0002274) | 2.55199664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.55730446 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.49343735 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.40689472 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.91902347 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.85156876 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.84271501 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.64343167 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.60712906 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.52717059 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.42350839 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.15658301 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13813617 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.59113174 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.47896355 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.36851204 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.32935066 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.26723196 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.22518731 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.21871761 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.15019423 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00272558 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.7411864 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93449677 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.91935450 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89565822 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.83804922 |
| 27 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.83079168 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.81826421 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.78753861 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.76339460 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76008194 |
| 32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75564238 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71336250 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.70837322 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70641069 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67650369 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67284117 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67147486 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.65714256 |
| 40 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60907461 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49929637 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.49579332 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48263146 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47962320 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44191303 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.42627279 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41607017 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40583608 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.39223971 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37757915 |
| 51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37322305 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.35600235 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35556957 |
| 54 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34983469 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33800509 |
| 56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29077163 |
| 57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27654938 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27405862 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27135557 |
| 60 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26529400 |
| 61 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.25747291 |
| 62 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21711204 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19169667 |
| 64 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18754662 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.18050733 |
| 66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15950811 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14539571 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13355003 |
| 69 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13276157 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.13193489 |
| 71 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12768587 |
| 72 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12768587 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10713918 |
| 74 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08841940 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06287719 |
| 76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04886091 |
| 77 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.02153996 |
| 78 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01163306 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00680071 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99679873 |
| 81 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94357185 |
| 82 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94287864 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91756428 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88975816 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87861754 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85920929 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.80612326 |
| 88 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80485769 |
| 89 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.79804562 |
| 90 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79579808 |
| 91 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79075498 |
| 92 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76037321 |
| 93 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.74604117 |
| 94 | MAF_26560356_Chip-Seq_TH2_Human | 0.74134762 |
| 95 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.73423948 |
| 96 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73270716 |
| 97 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.73161602 |
| 98 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.72939151 |
| 99 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72817636 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72609095 |
| 101 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.72581426 |
| 102 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.71416145 |
| 103 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69688771 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67603931 |
| 105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67493554 |
| 106 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.66661914 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.66306577 |
| 108 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.65882378 |
| 109 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.64214806 |
| 110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63826061 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.63789038 |
| 112 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.63071539 |
| 113 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.62736095 |
| 114 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.62121674 |
| 115 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.61100733 |
| 116 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.60631342 |
| 117 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60429230 |
| 118 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.58308257 |
| 119 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.57995916 |
| 120 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57267227 |
| 121 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.56854307 |
| 122 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.56582644 |
| 123 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55215965 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.54787289 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54587031 |
| 126 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54017050 |
| 127 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53614280 |
| 128 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.53075183 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.52218572 |
| 130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.52049750 |
| 131 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51884609 |
| 132 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.51540475 |
| 133 | CJUN_26792858_Chip-Seq_BT549_Human | 0.50479025 |
| 134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.50416156 |
| 135 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.49503548 |
| 136 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.47758878 |
| 137 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.47546518 |
| 138 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.47354122 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46533179 |
| 140 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46500410 |
| 141 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46287299 |
| 142 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.46093210 |
| 143 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.45768415 |
| 144 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.45582630 |
| 145 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.44630408 |
| 146 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.44497606 |
| 147 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.44072541 |
| 148 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.43570312 |
| 149 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.43556241 |
| 150 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43405155 |
| 151 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.43077337 |
| 152 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.43016626 |
| 153 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.42734553 |
| 154 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.42392520 |
| 155 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.41786557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.58758959 |
| 2 | MP0005360_urolithiasis | 6.90454849 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.72739261 |
| 4 | MP0005365_abnormal_bile_salt | 5.54957665 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.56727082 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.70397156 |
| 7 | MP0003252_abnormal_bile_duct | 3.53311795 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.39994281 |
| 9 | MP0009840_abnormal_foam_cell | 3.24452254 |
| 10 | MP0003195_calcinosis | 2.90072963 |
| 11 | MP0005083_abnormal_biliary_tract | 2.77649222 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.69319694 |
| 13 | MP0005332_abnormal_amino_acid | 2.62837820 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.28552492 |
| 15 | MP0001800_abnormal_humoral_immune | 2.20252345 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.12079223 |
| 17 | MP0000609_abnormal_liver_physiology | 2.08294838 |
| 18 | MP0003828_pulmonary_edema | 2.08166840 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.05765854 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.03036180 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.01121854 |
| 22 | MP0005671_abnormal_response_to | 2.00639590 |
| 23 | MP0002723_abnormal_immune_serum | 1.99502989 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.98508020 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.98419522 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.82636618 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.82361287 |
| 28 | MP0001819_abnormal_immune_cell | 1.80733622 |
| 29 | MP0003186_abnormal_redox_activity | 1.68486934 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.61704496 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.61704496 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58219026 |
| 33 | MP0009697_abnormal_copulation | 1.57480644 |
| 34 | MP0002405_respiratory_system_inflammati | 1.57441386 |
| 35 | MP0001764_abnormal_homeostasis | 1.56614433 |
| 36 | MP0009764_decreased_sensitivity_to | 1.56554335 |
| 37 | MP0002132_abnormal_respiratory_system | 1.52393467 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.52011563 |
| 39 | MP0003868_abnormal_feces_composition | 1.50268595 |
| 40 | MP0008004_abnormal_stomach_pH | 1.46464924 |
| 41 | MP0009278_abnormal_bone_marrow | 1.46331168 |
| 42 | MP0008260_abnormal_autophagy | 1.42656477 |
| 43 | MP0003724_increased_susceptibility_to | 1.41551313 |
| 44 | MP0003011_delayed_dark_adaptation | 1.40288662 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.39419444 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.37921018 |
| 47 | MP0003436_decreased_susceptibility_to | 1.37675198 |
| 48 | MP0005451_abnormal_body_composition | 1.37386195 |
| 49 | MP0001851_eye_inflammation | 1.32032008 |
| 50 | MP0000716_abnormal_immune_system | 1.31512994 |
| 51 | MP0000604_amyloidosis | 1.30229078 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.29438179 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.28399596 |
| 54 | MP0008469_abnormal_protein_level | 1.24291998 |
| 55 | MP0004947_skin_inflammation | 1.23613876 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.23387870 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.22333749 |
| 58 | MP0000858_altered_metastatic_potential | 1.21453136 |
| 59 | MP0002398_abnormal_bone_marrow | 1.21148094 |
| 60 | MP0002254_reproductive_system_inflammat | 1.21038600 |
| 61 | MP0009763_increased_sensitivity_to | 1.19550846 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.19069145 |
| 63 | MP0000689_abnormal_spleen_morphology | 1.14749207 |
| 64 | MP0000598_abnormal_liver_morphology | 1.13639403 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 1.08701740 |
| 66 | MP0010368_abnormal_lymphatic_system | 1.07247869 |
| 67 | MP0000569_abnormal_digit_pigmentation | 1.07031262 |
| 68 | MP0003690_abnormal_glial_cell | 1.06998112 |
| 69 | MP0003763_abnormal_thymus_physiology | 1.06738001 |
| 70 | MP0002722_abnormal_immune_system | 1.04532901 |
| 71 | MP0006082_CNS_inflammation | 1.04500907 |
| 72 | MP0009785_altered_susceptibility_to | 1.02791309 |
| 73 | MP0003866_abnormal_defecation | 1.00223359 |
| 74 | MP0005647_abnormal_sex_gland | 1.00163722 |
| 75 | MP0002429_abnormal_blood_cell | 0.99618981 |
| 76 | MP0001835_abnormal_antigen_presentation | 0.98959109 |
| 77 | MP0002876_abnormal_thyroid_physiology | 0.98536369 |
| 78 | MP0003075_altered_response_to | 0.97538683 |
| 79 | MP0005464_abnormal_platelet_physiology | 0.94674707 |
| 80 | MP0009333_abnormal_splenocyte_physiolog | 0.93597574 |
| 81 | MP0003448_altered_tumor_morphology | 0.93313331 |
| 82 | MP0001958_emphysema | 0.91910412 |
| 83 | MP0005670_abnormal_white_adipose | 0.91627184 |
| 84 | MP0006054_spinal_hemorrhage | 0.90808296 |
| 85 | MP0002419_abnormal_innate_immunity | 0.90391581 |
| 86 | MP0004510_myositis | 0.88254871 |
| 87 | MP0009642_abnormal_blood_homeostasis | 0.88115291 |
| 88 | MP0002396_abnormal_hematopoietic_system | 0.86328263 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.86029666 |
| 90 | MP0005058_abnormal_lysosome_morphology | 0.85871424 |
| 91 | MP0004130_abnormal_muscle_cell | 0.85025907 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 0.84479322 |
| 93 | MP0005408_hypopigmentation | 0.83434726 |
| 94 | MP0005390_skeleton_phenotype | 0.82966578 |
| 95 | MP0005535_abnormal_body_temperature | 0.82485545 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.82272389 |
| 97 | MP0005310_abnormal_salivary_gland | 0.80588772 |
| 98 | MP0002009_preneoplasia | 0.79588630 |
| 99 | MP0002971_abnormal_brown_adipose | 0.78907697 |
| 100 | MP0002006_tumorigenesis | 0.78604948 |
| 101 | MP0005166_decreased_susceptibility_to | 0.75836044 |
| 102 | MP0005025_abnormal_response_to | 0.74954563 |
| 103 | MP0005334_abnormal_fat_pad | 0.74601925 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.74468906 |
| 105 | MP0005164_abnormal_response_to | 0.74016577 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.73939371 |
| 107 | MP0001853_heart_inflammation | 0.73561013 |
| 108 | MP0001663_abnormal_digestive_system | 0.71737739 |
| 109 | MP0002277_abnormal_respiratory_mucosa | 0.71485387 |
| 110 | MP0001845_abnormal_inflammatory_respons | 0.71058918 |
| 111 | MP0001533_abnormal_skeleton_physiology | 0.69942574 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 0.67328332 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.67049875 |
| 114 | MP0004883_abnormal_blood_vessel | 0.65733127 |
| 115 | MP0001756_abnormal_urination | 0.64848844 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 0.63054863 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.62594359 |
| 118 | MP0005275_abnormal_skin_tensile | 0.61111754 |
| 119 | MP0002148_abnormal_hypersensitivity_rea | 0.61004785 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.60568693 |
| 121 | MP0001661_extended_life_span | 0.60486281 |
| 122 | MP0000249_abnormal_blood_vessel | 0.59807385 |
| 123 | MP0005448_abnormal_energy_balance | 0.56298601 |
| 124 | MP0002295_abnormal_pulmonary_circulatio | 0.55485530 |
| 125 | MP0009053_abnormal_anal_canal | 0.53603657 |
| 126 | MP0005220_abnormal_exocrine_pancreas | 0.50813626 |
| 127 | MP0009115_abnormal_fat_cell | 0.50494884 |
| 128 | MP0008873_increased_physiological_sensi | 0.49508999 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.48981223 |
| 130 | MP0005266_abnormal_metabolism | 0.48548191 |
| 131 | MP0000685_abnormal_immune_system | 0.48367079 |
| 132 | MP0003329_amyloid_beta_deposits | 0.48207937 |
| 133 | MP0001790_abnormal_immune_system | 0.48195591 |
| 134 | MP0005387_immune_system_phenotype | 0.48195591 |
| 135 | MP0003638_abnormal_response/metabolism_ | 0.47384045 |
| 136 | MP0000343_altered_response_to | 0.46984054 |
| 137 | MP0005395_other_phenotype | 0.46955390 |
| 138 | MP0005000_abnormal_immune_tolerance | 0.45959591 |
| 139 | MP0000639_abnormal_adrenal_gland | 0.44790554 |
| 140 | MP0002168_other_aberrant_phenotype | 0.43854203 |
| 141 | MP0001243_abnormal_dermal_layer | 0.43436479 |
| 142 | MP0003303_peritoneal_inflammation | 0.41576471 |
| 143 | MP0008874_decreased_physiological_sensi | 0.40443497 |
| 144 | MP0002090_abnormal_vision | 0.39891814 |
| 145 | MP0005666_abnormal_adipose_tissue | 0.39074647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.90033696 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.55683723 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.49435592 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.39302089 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.10358351 |
| 6 | Xanthomatosis (HP:0000991) | 5.95642682 |
| 7 | Complement deficiency (HP:0004431) | 5.68796543 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.67459317 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.20140451 |
| 10 | Joint hemorrhage (HP:0005261) | 5.12423799 |
| 11 | Recurrent abscess formation (HP:0002722) | 5.06917532 |
| 12 | Myositis (HP:0100614) | 4.87171113 |
| 13 | Orchitis (HP:0100796) | 4.71580626 |
| 14 | Optic neuritis (HP:0100653) | 4.49044764 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 4.49044764 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.45745359 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.42481016 |
| 18 | Abnormality of complement system (HP:0005339) | 4.35956622 |
| 19 | Abnormality of macrophages (HP:0004311) | 4.35053459 |
| 20 | Epidermoid cyst (HP:0200040) | 4.22484030 |
| 21 | Hyperammonemia (HP:0001987) | 4.21848003 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12948902 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.12393860 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 4.10316046 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 3.94144116 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.93276999 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.88942849 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.88107166 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.85766262 |
| 30 | Fat malabsorption (HP:0002630) | 3.85611979 |
| 31 | Hyperglycinemia (HP:0002154) | 3.83719151 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.78826782 |
| 33 | Ketosis (HP:0001946) | 3.77865521 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.64130382 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 3.58883415 |
| 36 | Hyperglycinuria (HP:0003108) | 3.57862507 |
| 37 | Stomatitis (HP:0010280) | 3.55255286 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.49423356 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.47550136 |
| 40 | Abnormality of glycine metabolism (HP:0010895) | 3.47492914 |
| 41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.47492914 |
| 42 | Myocardial infarction (HP:0001658) | 3.43857679 |
| 43 | Recurrent skin infections (HP:0001581) | 3.43384900 |
| 44 | Spontaneous hematomas (HP:0007420) | 3.43095621 |
| 45 | Gastrointestinal infarctions (HP:0005244) | 3.41939099 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 3.40632753 |
| 47 | Keratoconjunctivitis sicca (HP:0001097) | 3.38962427 |
| 48 | Glomerulonephritis (HP:0000099) | 3.34459553 |
| 49 | Obstructive lung disease (HP:0006536) | 3.32249053 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 3.32249053 |
| 51 | Meningitis (HP:0001287) | 3.24138986 |
| 52 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.22174684 |
| 53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.22174684 |
| 54 | Abnormality of glycolipid metabolism (HP:0010969) | 3.22174684 |
| 55 | Epistaxis (HP:0000421) | 3.20273398 |
| 56 | Recurrent fungal infections (HP:0002841) | 3.18682761 |
| 57 | Mediastinal lymphadenopathy (HP:0100721) | 3.18170990 |
| 58 | Gingivitis (HP:0000230) | 3.16685666 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.14209669 |
| 60 | Prolonged bleeding time (HP:0003010) | 3.10888618 |
| 61 | Keratoconjunctivitis (HP:0001096) | 3.10017037 |
| 62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.09501656 |
| 63 | Hemoptysis (HP:0002105) | 3.06304816 |
| 64 | Steatorrhea (HP:0002570) | 3.04442819 |
| 65 | Pulmonary infiltrates (HP:0002113) | 3.00213408 |
| 66 | Spontaneous abortion (HP:0005268) | 2.98405820 |
| 67 | Hyperbilirubinemia (HP:0002904) | 2.97347726 |
| 68 | Vasculitis (HP:0002633) | 2.97306561 |
| 69 | Arterial thrombosis (HP:0004420) | 2.93623671 |
| 70 | Abnormality of nucleobase metabolism (HP:0010932) | 2.92768423 |
| 71 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91937344 |
| 72 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91937344 |
| 73 | Amyloidosis (HP:0011034) | 2.89630835 |
| 74 | Purpura (HP:0000979) | 2.84859796 |
| 75 | Hepatocellular carcinoma (HP:0001402) | 2.84795238 |
| 76 | Peritonitis (HP:0002586) | 2.83839973 |
| 77 | Vascular calcification (HP:0004934) | 2.78958218 |
| 78 | Encephalitis (HP:0002383) | 2.77388812 |
| 79 | Increased cerebral lipofuscin (HP:0011813) | 2.76771703 |
| 80 | Urticaria (HP:0001025) | 2.75518122 |
| 81 | Skin nodule (HP:0200036) | 2.75242577 |
| 82 | Gangrene (HP:0100758) | 2.73494165 |
| 83 | Abnormality of serum amino acid levels (HP:0003112) | 2.71851774 |
| 84 | Delayed CNS myelination (HP:0002188) | 2.70323001 |
| 85 | Ketoacidosis (HP:0001993) | 2.70135310 |
| 86 | Chest pain (HP:0100749) | 2.69265439 |
| 87 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.68992479 |
| 88 | Dysostosis multiplex (HP:0000943) | 2.61352260 |
| 89 | Mitral stenosis (HP:0001718) | 2.60780278 |
| 90 | Abnormality of purine metabolism (HP:0004352) | 2.57087443 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.55500478 |
| 92 | Metabolic acidosis (HP:0001942) | 2.53937544 |
| 93 | Gingival bleeding (HP:0000225) | 2.53796703 |
| 94 | Episodic fever (HP:0001954) | 2.40193097 |
| 95 | Anorexia (HP:0002039) | 2.38625384 |
| 96 | Hypochromic microcytic anemia (HP:0004840) | 2.38159976 |
| 97 | Nephritis (HP:0000123) | 2.37745205 |
| 98 | Abnormality of the pleura (HP:0002103) | 2.36229126 |
| 99 | Loss of speech (HP:0002371) | 2.35417185 |
| 100 | Esophageal varix (HP:0002040) | 2.34905152 |
| 101 | Leukocytosis (HP:0001974) | 2.33421536 |
| 102 | Lethargy (HP:0001254) | 2.31344839 |
| 103 | Sensorimotor neuropathy (HP:0007141) | 2.30753892 |
| 104 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.30584965 |
| 105 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.30584965 |
| 106 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.30584965 |
| 107 | Dicarboxylic aciduria (HP:0003215) | 2.30105463 |
| 108 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30105463 |
| 109 | Menorrhagia (HP:0000132) | 2.29146174 |
| 110 | Mucopolysacchariduria (HP:0008155) | 2.28782997 |
| 111 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28782997 |
| 112 | Vacuolated lymphocytes (HP:0001922) | 2.26975849 |
| 113 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.26924494 |
| 114 | Thrombophlebitis (HP:0004418) | 2.26824257 |
| 115 | Increased serum ferritin (HP:0003281) | 2.26416235 |
| 116 | Pancreatitis (HP:0001733) | 2.24791601 |
| 117 | Hemorrhage of the eye (HP:0011885) | 2.21466414 |
| 118 | T lymphocytopenia (HP:0005403) | 2.20221334 |
| 119 | Spastic diplegia (HP:0001264) | 2.19761354 |
| 120 | Hypoglycemic seizures (HP:0002173) | 2.19226493 |
| 121 | Abnormal gallbladder morphology (HP:0012437) | 2.17094701 |
| 122 | Interstitial pulmonary disease (HP:0006530) | 2.16528125 |
| 123 | Abnormality of T cell number (HP:0011839) | 2.16012677 |
| 124 | Cellulitis (HP:0100658) | 2.15907828 |
| 125 | Hydroxyprolinuria (HP:0003080) | 2.15313841 |
| 126 | Abnormality of proline metabolism (HP:0010907) | 2.15313841 |
| 127 | Polycythemia (HP:0001901) | 2.15245320 |
| 128 | Cerebral edema (HP:0002181) | 2.13535924 |
| 129 | Recurrent viral infections (HP:0004429) | 2.13173274 |
| 130 | Cholelithiasis (HP:0001081) | 2.11286085 |
| 131 | Irritability (HP:0000737) | 2.10488196 |
| 132 | Increased IgE level (HP:0003212) | 2.10154791 |
| 133 | Acanthocytosis (HP:0001927) | 2.07499225 |
| 134 | Axonal loss (HP:0003447) | 2.06901403 |
| 135 | Periodontitis (HP:0000704) | 2.06475693 |
| 136 | Vertigo (HP:0002321) | 2.05885802 |
| 137 | Abnormal platelet volume (HP:0011876) | 2.05795833 |
| 138 | Polyneuropathy (HP:0001271) | 2.04958658 |
| 139 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.04717203 |
| 140 | Petechiae (HP:0000967) | 2.03501782 |
| 141 | Generalized aminoaciduria (HP:0002909) | 2.01657061 |
| 142 | Glomerulopathy (HP:0100820) | 2.01404714 |
| 143 | Inflammation of the large intestine (HP:0002037) | 2.01256524 |
| 144 | Abnormality of the peritoneum (HP:0002585) | 2.00591291 |
| 145 | Abnormality of iron homeostasis (HP:0011031) | 2.00440495 |
| 146 | Acne (HP:0001061) | 1.99845774 |
| 147 | Osteomyelitis (HP:0002754) | 1.99563013 |
| 148 | Cholecystitis (HP:0001082) | 1.99372899 |
| 149 | Abnormal gallbladder physiology (HP:0012438) | 1.99372899 |
| 150 | Nausea (HP:0002018) | 1.99289321 |
| 151 | Neonatal onset (HP:0003623) | 1.98838659 |
| 152 | Enlarged kidneys (HP:0000105) | 1.96872367 |
| 153 | Vomiting (HP:0002013) | 1.96809862 |
| 154 | Gout (HP:0001997) | 1.95857415 |
| 155 | Hypophosphatemic rickets (HP:0004912) | 1.95366190 |
| 156 | Malnutrition (HP:0004395) | 1.93485461 |
| 157 | Hematochezia (HP:0002573) | 1.92675546 |
| 158 | Pulmonary embolism (HP:0002204) | 1.92404422 |
| 159 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92006343 |
| 160 | Opisthotonus (HP:0002179) | 1.91594309 |
| 161 | Disinhibition (HP:0000734) | 1.90552822 |
| 162 | Thrombocytosis (HP:0001894) | 1.90036190 |
| 163 | Abnormal cartilage morphology (HP:0002763) | 1.87927053 |
| 164 | Rickets (HP:0002748) | 1.84355670 |
| 165 | Hypertriglyceridemia (HP:0002155) | 1.80936832 |
| 166 | Alkalosis (HP:0001948) | 1.80236553 |
| 167 | Eczematoid dermatitis (HP:0000976) | 1.78841776 |
| 168 | Abnormality of the gallbladder (HP:0005264) | 1.77777764 |
| 169 | Upper motor neuron abnormality (HP:0002127) | 1.77421875 |
| 170 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77106960 |
| 171 | Elevated hepatic transaminases (HP:0002910) | 1.76515653 |
| 172 | Joint swelling (HP:0001386) | 1.75229308 |
| 173 | Recurrent bacterial skin infections (HP:0005406) | 1.74688446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.33832428 |
| 2 | ERN1 | 4.43339933 |
| 3 | FGFR4 | 3.55099675 |
| 4 | SIK1 | 3.46506932 |
| 5 | MAP3K14 | 2.96503788 |
| 6 | FES | 2.61307811 |
| 7 | INSRR | 2.61273094 |
| 8 | TYK2 | 2.42806036 |
| 9 | MST1R | 2.36312242 |
| 10 | ERBB4 | 2.31667539 |
| 11 | TAOK3 | 2.25786184 |
| 12 | TBK1 | 2.13636343 |
| 13 | BLK | 2.11784146 |
| 14 | PBK | 2.11009915 |
| 15 | PRPF4B | 2.01992503 |
| 16 | ABL2 | 1.91159121 |
| 17 | IRAK3 | 1.84522042 |
| 18 | TNK2 | 1.67796379 |
| 19 | NEK9 | 1.63941783 |
| 20 | BTK | 1.62553451 |
| 21 | JAK1 | 1.58291452 |
| 22 | RIPK4 | 1.57636664 |
| 23 | PIK3CG | 1.56639644 |
| 24 | TRIB3 | 1.51596087 |
| 25 | TEC | 1.46087128 |
| 26 | MAP2K4 | 1.43002495 |
| 27 | FLT3 | 1.41502621 |
| 28 | PKN2 | 1.39370723 |
| 29 | IKBKE | 1.38796340 |
| 30 | FGR | 1.37644569 |
| 31 | JAK2 | 1.35939527 |
| 32 | DAPK2 | 1.35776856 |
| 33 | MAPK11 | 1.35681321 |
| 34 | TGFBR2 | 1.35364508 |
| 35 | CSK | 1.24391282 |
| 36 | TAOK1 | 1.23802279 |
| 37 | KDR | 1.20200034 |
| 38 | MATK | 1.20071139 |
| 39 | YES1 | 1.19520767 |
| 40 | MAP3K3 | 1.13375359 |
| 41 | IKBKB | 1.10986309 |
| 42 | MAP3K6 | 1.09685917 |
| 43 | ITK | 1.09358200 |
| 44 | FRK | 1.08442370 |
| 45 | EPHA3 | 1.08419672 |
| 46 | LCK | 1.08023132 |
| 47 | MAP2K3 | 1.05197035 |
| 48 | PTK6 | 1.04425294 |
| 49 | MAP3K2 | 1.02685397 |
| 50 | BMPR2 | 0.93843358 |
| 51 | CSF1R | 0.91575158 |
| 52 | LATS1 | 0.90874316 |
| 53 | MAP3K13 | 0.89991727 |
| 54 | CAMKK2 | 0.88507350 |
| 55 | JAK3 | 0.88239040 |
| 56 | EPHB1 | 0.86180387 |
| 57 | PRKAA2 | 0.85218123 |
| 58 | CAMK1D | 0.84417852 |
| 59 | IRAK4 | 0.84341755 |
| 60 | STK38L | 0.84082157 |
| 61 | MAP3K11 | 0.82059759 |
| 62 | MAPK4 | 0.81881684 |
| 63 | TIE1 | 0.80068661 |
| 64 | KIT | 0.79517600 |
| 65 | TRPM7 | 0.78687162 |
| 66 | TAOK2 | 0.76114811 |
| 67 | MAPK12 | 0.75519456 |
| 68 | KSR2 | 0.75364935 |
| 69 | MARK3 | 0.74819897 |
| 70 | IRAK1 | 0.73754601 |
| 71 | MET | 0.73070641 |
| 72 | PINK1 | 0.72647995 |
| 73 | PRKCZ | 0.70544113 |
| 74 | FGFR3 | 0.70204026 |
| 75 | CDC42BPA | 0.69820241 |
| 76 | MARK2 | 0.69223599 |
| 77 | BMX | 0.69022981 |
| 78 | STK3 | 0.68856536 |
| 79 | EPHB2 | 0.66323384 |
| 80 | CHUK | 0.64999160 |
| 81 | ACVR1B | 0.64508897 |
| 82 | RIPK1 | 0.64474057 |
| 83 | ERBB2 | 0.62602790 |
| 84 | SGK2 | 0.62107080 |
| 85 | CDK6 | 0.61859189 |
| 86 | PRKACG | 0.61714192 |
| 87 | GRK6 | 0.61528509 |
| 88 | MAP3K5 | 0.58630757 |
| 89 | GSK3A | 0.58032717 |
| 90 | IGF1R | 0.57982793 |
| 91 | ZAP70 | 0.56775651 |
| 92 | MAP4K1 | 0.56648796 |
| 93 | LRRK2 | 0.56314204 |
| 94 | LYN | 0.56246256 |
| 95 | NLK | 0.56235794 |
| 96 | MAPK7 | 0.55802130 |
| 97 | PRKCQ | 0.55397485 |
| 98 | FYN | 0.54818681 |
| 99 | TXK | 0.53074447 |
| 100 | PDPK1 | 0.52197875 |
| 101 | MAP3K7 | 0.51605756 |
| 102 | HIPK2 | 0.50942825 |
| 103 | STK10 | 0.48937793 |
| 104 | MOS | 0.48744936 |
| 105 | EGFR | 0.48681329 |
| 106 | NME2 | 0.48358226 |
| 107 | PIK3CA | 0.47743716 |
| 108 | ABL1 | 0.47567243 |
| 109 | PTK2B | 0.47056838 |
| 110 | MAP2K6 | 0.46202265 |
| 111 | PRKCD | 0.46090427 |
| 112 | MAP3K10 | 0.46038553 |
| 113 | RPS6KL1 | 0.45380161 |
| 114 | RPS6KC1 | 0.45380161 |
| 115 | CAMK2G | 0.44959852 |
| 116 | PIM2 | 0.43756793 |
| 117 | DYRK1B | 0.43430365 |
| 118 | RET | 0.42863101 |
| 119 | PDGFRB | 0.41865881 |
| 120 | HCK | 0.41761201 |
| 121 | SGK3 | 0.41293275 |
| 122 | GRK7 | 0.41250502 |
| 123 | PRKD2 | 0.40981325 |
| 124 | MAP2K1 | 0.40342508 |
| 125 | RPS6KA6 | 0.39927997 |
| 126 | STK11 | 0.38493298 |
| 127 | FGFR2 | 0.37895031 |
| 128 | IRAK2 | 0.37391604 |
| 129 | MYLK | 0.36444913 |
| 130 | MAPKAPK2 | 0.36421073 |
| 131 | PRKD1 | 0.36130022 |
| 132 | GRK1 | 0.35614484 |
| 133 | PIM1 | 0.35518447 |
| 134 | NUAK1 | 0.33831004 |
| 135 | PDK2 | 0.33646398 |
| 136 | SYK | 0.32953333 |
| 137 | MAPK15 | 0.32903559 |
| 138 | EIF2AK2 | 0.31710398 |
| 139 | PDK1 | 0.30037722 |
| 140 | MAP3K1 | 0.29474156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.47731196 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.38754243 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32709434 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31658253 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.08294102 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98797027 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60750512 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55697139 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.52183124 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45064537 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.43251228 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.42635207 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41657243 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.40987828 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33160550 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30584625 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.15114607 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.14623151 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14459341 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.98205510 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97860076 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.97155995 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95417149 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.94268172 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91749096 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90827385 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86637081 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84571302 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80100329 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77336021 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.75984613 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71934728 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.66232557 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65000604 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63944607 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58679176 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55481379 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50025238 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46924121 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.46105070 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44695397 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.44435714 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41419054 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.37513908 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37060534 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35798248 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35322638 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32996778 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.30324309 |
| 50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.29815439 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28369493 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.25678167 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25229088 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22258908 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.22232498 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19359223 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15923221 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.14818845 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 1.12355669 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11312239 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10066394 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09031324 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 1.08859485 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07149158 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06731232 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03100252 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02617143 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02576056 |
| 69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01651854 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00988314 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.99757312 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98601806 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97844272 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94348313 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91592369 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90580720 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84936460 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81232049 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78256269 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.77894066 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76409833 |
| 82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75201603 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70081595 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69639586 |
| 85 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.69155114 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66713095 |
| 87 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65176937 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64372252 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64110601 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.61818955 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.61683930 |
| 92 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60991396 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59460337 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.59272945 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57836126 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56868723 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55185580 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52809073 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.52250978 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51443106 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51268057 |
| 102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50699339 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49905642 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49479468 |
| 105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43111325 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41368522 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39796045 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39489561 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.39198348 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36246101 |
| 111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36153104 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.35059235 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35035631 |
| 114 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.34630101 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34495112 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34245873 |
| 117 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34043673 |
| 118 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.28252641 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26626012 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26576919 |
| 121 | Malaria_Homo sapiens_hsa05144 | 0.24637634 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.24602817 |
| 123 | Pertussis_Homo sapiens_hsa05133 | 0.22487956 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20842161 |
| 125 | Legionellosis_Homo sapiens_hsa05134 | 0.20494764 |
| 126 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.17113118 |
| 127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16535656 |
| 128 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.13000757 |
| 129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.11740798 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.10690379 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.09599121 |
| 132 | Leishmaniasis_Homo sapiens_hsa05140 | 0.09278475 |
| 133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.06499496 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.05108503 |
| 135 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.04961544 |
| 136 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.00964462 |
| 137 | Allograft rejection_Homo sapiens_hsa05330 | -0.0664697 |
| 138 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0655836 |
| 139 | Hepatitis C_Homo sapiens_hsa05160 | -0.0427615 |
| 140 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0384100 |
| 141 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0364871 |
| 142 | Rheumatoid arthritis_Homo sapiens_hsa05323 | -0.0297457 |
| 143 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0277153 |
| 144 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0273644 |
| 145 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.0255984 |
| 146 | Tuberculosis_Homo sapiens_hsa05152 | -0.0252254 |
| 147 | Amoebiasis_Homo sapiens_hsa05146 | -0.0134153 |
| 148 | Phagosome_Homo sapiens_hsa04145 | -0.0004668 |

